COMPANY
Slate Medicines
Funding and NIH signals
- SEC Form D raise Raised $10M (Form D filed Mar 11, 2026). SEC Form D 0001231919-26-000246 (Mar 11, 2026)
Evidence (1 event)
- Mar 11, 2026 · SEC Form D 0001231919-26-000246
Name of Issuer: Slate Medicines, Inc.; CIK: 2117806; Address: Boston, MA; Submission type: D; Filing date: 2026-03-11; Industry Group: Pharmaceuticals; Date of First Sale: 2026-02-17; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 130000000; Total Amount Sold: 9999992; Federal exemptions: 06b
- Mar 11, 2026 · SEC Form D 0001231919-26-000246